Development and Validation of a Virtual Teaching Method for Minimally Invasive Surgery Skills
- Disease/Condition
- Surgery
- Drug/Device/Intervention
- Virtual teaching
- Study type
- Interventional
- Intervention type
- other
- Primary sponsor
- Imperial College London
- Location
- London, United Kingdom
- Phase
- N/A
- Start date
- Mar 11, 2022
- End date
- Apr 08, 2022
- Enrollment
- 20 participants
McGill Inanimate System for Training and Evaluation of Laparoscopic Skills (MISTELS) peg transfer task score,European Academy laparoscopic 'Suturing Training and Testing' (SUTT) assessment score
The goal of this observational study is to develop and evaluate a virtual teaching method for
 minimally invasive surgery (MIS) skills among novice learners, using widely available
 technology and incorporating objective assessments of proficiency. The main questions it aims
 to answer are:
 
 Can MIS skills be effectively taught to novice learners through a virtual platform using
 widely available technology? How do virtual and face-to-face (F2F) teaching methods compare
 in terms of effectiveness, measured by performance in MIS tasks and cognitive workload
 parameters?
 
 Participants in this study will:
 
 Be randomly allocated to either F2F or virtual teaching groups. Undergo training and
 evaluation using validated laparoscopic assessments, namely the McGill Inanimate System for
 Training and Evaluation of Laparoscopic Skills (MISTELS) peg transfer task and the European
 Academy laparoscopic 'Suturing Training and Testing' (SUTT) assessment.
 
 Have their performance and cognitive workload parameters (SURG-TLX score, heart rate, and
 pupil metrics) evaluated during the tasks.
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT06355596
- Type
- Non-Device Trial
Access comprehensive clinical trial information for NCT06355596 through Pure Global AI's free database. This phase not specified trial is sponsored by Imperial College London and is currently Completed. The study focuses on Surgery. Target enrollment is 20 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.